GRAIL, Inc.

GRAIL, Inc.

GRAL · Nasdaq

GRAIL, Inc. (GRAL) is a Medical diagnostics research company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for GRAIL, Inc. in 2026. The next earnings report is expected on November 18, 2026.

Earnings calendar

Next earnings date

18 Nov 2026

In 90 days

EPS estimate

-2.67

Revenue estimate

44.2M

Past earnings

05 Aug 2026
EPS actual
-2.56 (+3.6%)
estimate -2.66
Revenue actual
44.7M (+5.4%)
estimate 42.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
05 May 2026
EPS actual
-2.29 (+17.1%)
estimate -2.76
Revenue actual
40.8M (+4.2%)
estimate 39.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
19 Feb 2026
EPS actual
-2.44 (+9.6%)
estimate -2.70
Revenue actual
43.6M (+0.0%)
estimate 43.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

GRAIL, Inc. beat consensus estimates in its latest earnings report, with EPS of -$2.56 beating the -$2.6556 estimate and revenue of $44.69 million exceeding the $42.39 million estimate by 5.4%. In the prior quarter both EPS and revenue also came in ahead of expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

Sector
Healthcare
Industry
Medical diagnostics research
Country
United States
Exchange
Nasdaq
CEO
Robert Ragusa
Employees
1,000
IPO date
12 Jun 2024
ISIN
US3847471014
Website
grail.com

Frequently asked questions

When does GRAIL, Inc. (GRAL) next report earnings?

GRAIL, Inc. (GRAL) is scheduled to report earnings on November 18, 2026.

What was GRAIL, Inc.'s most recent earnings date?

GRAIL, Inc. (GRAL) last reported earnings on August 5, 2026.

Where is GRAIL, Inc. stock listed?

GRAIL, Inc. (GRAL) is listed on Nasdaq.